Archives: Artículos y patentes
EGFR and PTEN gene alterations predicts survival in patients with brain tumors
Polyethylene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation
Multiple immunofluorescence assay identifies upregulation of Active β‑catenin in prostate cancer
Pere Puig , Nadina Erill, Marta Terricabras, Isaac Subirana, Judit González‑García, Adrià Asensi‑Puig, Michael J. Donovan, Lourdes Mengual, M. Teresa Agulló‑Ortuño, Mireia Olivan, Antonio Alcaraz, José A. López‑Martín, Inés de Torres, José Luis Rodríguez‑Peralto, Alfredo Rodríguez‑Antolín, Juan Morote and Víctor González‑Rumayor.
ImaGEO: integrative gene expression meta-analysis from GEO database
Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer
Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis
MLlipsy Santiago 1, Cheikh Menaa 2, Maykel Arias 1, Praxedis Martin 3, Paula Jaime-Sánchez 1, Sunil Metkar 4, Laura Comas 5, Nadina Erill 6, Victor Gonzalez-Rumayor 6, Erica Esser 2, Eva M Galvez 7, Sri Raja 2, Markus M Simon 8, Stuart M Sprague 2, Cem Gabay 3, Luis Martinez-Lostao 9, Julian Pardo 10, Christopher J Froelich
Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer
Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Alexandra Valera,1 Armando López-Guillermo,1 Teresa Cardesa-Salzmann,1 Fina Climent,2 Eva González-Barca,3 Santiago Mercadal,3 Íñigo Espinosa,4 Silvana Novelli,4 Javier Briones,4 José L. Mate,5 Olga Salamero,5 Juan M. Sancho,5 Leonor Arenillas,6 Sergi Serrano,6 Nadina Erill,7 Daniel Martínez,1 Paola Castillo,1 Jordina Rovira,1 Antonio Martínez,1 Elias Campo,1 and Luis Colomo1, Grup per l’Estudi dels Limfomes de Catalunya i Balears (GELCAB)